Skip to main content

SI-BONE, Inc.

For the period ended Dec 31, 2025. Filed Feb 24, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 24, 2026

SIBN$25.60+5.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

SI-BONE, Inc.
Date: February 24, 2026By:/s/ Laura A. Francis
Laura A. Francis
Chief Executive Officer
(Duly Authorized Officer and Principal Executive Officer)
SI-BONE, Inc.
Date: February 24, 2026By:/s/ Anshul Maheshwari
Anshul Maheshwari
Chief Operating Officer & Chief Financial Officer
(Principal Financial and Accounting Officer)

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Laura A. Francis, and Michael A. Pisetsky, and each of them, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him or her and in his or her name, place or stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10‑K, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Laura A. FrancisChief Executive Officer and Director(Duly Authorized Officer and Principal Executive Officer)February 24, 2026
Laura A. Francis
/s/ Anshul MaheshwariChief Operating Officer & Chief Financial Officer(Principal Financial and Accounting Officer)February 24, 2026
Anshul Maheshwari
/s/ Timothy E. Davis, Jr.DirectorFebruary 24, 2026
Timothy E. Davis, Jr.
/s/ Jeffrey W. DunnChairman of the Board of DirectorsFebruary 24, 2026
Jeffrey W. Dunn
/s/ John G. Freund, M.D.DirectorFebruary 24, 2026
John G. Freund, M.D.
/s/ Jeryl L. HillemanDirectorFebruary 24, 2026
Jeryl L. Hilleman
/s/ Gregory K. HinckleyDirectorFebruary 24, 2026
Gregory K. Hinckley
/s/ Mika NishimuraDirectorFebruary 24, 2026
Mika Nishimura
/s/ Thomas A. WestDirectorFebruary 24, 2026
Thomas A. West
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.